Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder | Zendy

Sharon B. Wigal | Zendy; Ann Childress | Zendy; Susan A. Berry | Zendy; Heidi W. Belden | Zendy; Faith Walters | Zendy; Phillip Chappell | Zendy; Nancy Sherman | Zendy; John Orazem | Zendy; Donna Palumbo | Zendy

Open Access

Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder

Author(s) -

Sharon B. Wigal,

Ann Childress,

Susan A. Berry,

Heidi W. Belden,

Faith Walters,

Phillip Chappell,

Nancy Sherman,

John Orazem,

Donna Palumbo

Publication year - 2017

Publication title -

journal of child and adolescent psychopharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.935

H-Index - 84

eISSN - 1557-8992

pISSN - 1044-5463

DOI - 10.1089/cap.2016.0177

Subject(s) - placebo , methylphenidate , adverse effect , attention deficit hyperactivity disorder , medicine , rating scale , confidence interval , psychology , psychiatry , developmental psychology , alternative medicine , pathology

This phase 3, laboratory classroom study assessed the efficacy and safety of methylphenidate hydrochloride extended-release chewable tablets (MPH ERCT) compared with placebo in children with attention-deficit/hyperactivity disorder (ADHD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research